An in-depth look to ADDEX THERAPEUTICS LIMITED CHF0.01 (REGD) operating, investing, and financing activities

0QNV free cash flow for Q3 24 is -400.33 k CHF. For 2023, 0QNV free cash flow was -7.96 M CHF and operating cash flow was -7.95 M CHF.